Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ocular Therapeutix, Inc. OCUL

Set alert

Price alert · OCUL

All alert types
6.73 USD -0.24 -3.44%

At close

6.80 +0.07 +1.04%

Pre-market · Nov 3, 8:12 AM ET

Bid
6.73 × 1
Ask
6.74 × 4
6.58 Day range 7.03
6.00 52-week range 16.44
YTD
-44.56%
1 year
-41.02%
Open
6.97
Prev close
6.97
Mkt cap
1.48B
Vol
1.88M
Avg vol
3.04M
EPS
-1.40
P/E
0.00
Div yield
0.00%
More statistics
Low
6.58
High
7.03
Forward P/E
-4.55
Beta
1.22
Short ratio
7.60
Inst. own
95.31%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
8.81
200-d avg
9.12
1y target
25.45

1D chart

Chart tools
Interval
1m5m15m30m

Signals (50)
NameTimeAgo
MACD: Sell Signal3:58 PM16 hours ago
SMA: Bearish3:55 PM16 hours ago
SMA: Bearish3:54 PM16 hours ago
SMA: Bullish3:52 PM16 hours ago
MACD: Buy Signal3:42 PM17 hours ago
RSI: Oversold3:28 PM17 hours ago
SMA: Bearish3:16 PM17 hours ago
MACD: Sell Signal3:11 PM17 hours ago
RSI: Overbought3:08 PM17 hours ago
MACD: Buy Signal3:06 PM17 hours ago
MACD: Sell Signal3:02 PM17 hours ago
MACD: Buy Signal3:01 PM17 hours ago
MACD: Sell Signal2:56 PM17 hours ago
RSI: Overbought2:46 PM17 hours ago
MACD: Buy Signal2:38 PM18 hours ago
MACD: Sell Signal2:33 PM18 hours ago
MACD: Buy Signal2:27 PM18 hours ago
MACD: Sell Signal2:22 PM18 hours ago
RSI: Overbought2:13 PM18 hours ago
MACD: Buy Signal2:05 PM18 hours ago

Newest 20 of 50.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 25.45 +278.2% upside
Target (low)
14.00
Target (mean)
25.45
Target (high)
34.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
  • Strong buy4
  • Buy8
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 11
  • 2 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OCUL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.3548-0.37 – -0.30-0.38+6.6%14.30M-1.7%6
Next quarter-0.37776-0.43 – -0.31-0.29-30.3%14.18M+7.0%6
Current year-1.44-1.54 – -1.18-1.42-1.7%52.84M+1.7%5
Next year-1.48-1.86 – -1.09-1.44-2.5%102.04M+93.1%6

Upgrades and downgrades

The latest rating changes

OCUL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 19, 2026NeedhamReiteratedBuyBuy
Oct 12, 2026UBSInitiated—Buy
Oct 2, 2026Chardan CapitalMaintainedBuyBuy
Sep 29, 2026NeedhamReiteratedBuyBuy
Sep 16, 2026Chardan CapitalMaintainedBuyBuy
Sep 16, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 4, 2026Chardan CapitalMaintainedBuyBuy
Jun 25, 2026Chardan CapitalMaintainedBuyBuy
Jun 18, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 18, 2026BairdMaintainedOutperformOutperform
May 6, 2026RBC CapitalReiteratedOutperformOutperform
May 5, 2026NeedhamReiteratedBuyBuy
Apr 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 3, 2026Clear StreetMaintainedBuyBuy
Feb 20, 2026NeedhamMaintainedBuyBuy
Feb 18, 2026Chardan CapitalMaintainedBuyBuy
Dec 9, 2025Chardan CapitalMaintainedBuyBuy
Dec 8, 2025NeedhamReiteratedBuyBuy
Dec 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 25, 2025HC Wainwright & Co.ReiteratedBuyBuy
Nov 5, 2025Chardan CapitalMaintainedBuyBuy
Oct 30, 2025TD CowenMaintainedBuyBuy
Oct 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 3, 2025Piper SandlerMaintainedOverweightOverweight
Oct 3, 2025BairdMaintainedOutperformOutperform
Oct 2, 2025Chardan CapitalMaintainedBuyBuy
Oct 1, 2025NeedhamMaintainedBuyBuy
Oct 1, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Sep 15, 2025Chardan CapitalInitiated—Buy
Aug 6, 2025ScotiabankMaintainedSector OutperformSector Outperform